Treatment of subclinical hypothyroidism linked with fewer ischemic heart events in younger patients

April 23, 2012

Treatment of subclinical hypothyroidism with the medication levothyroxine appears to be related to fewer ischemic heart disease events in younger patients but this finding was not evident in older patients, according to a report published Online First in Archives of Internal Medicine.

Subclinical hypothyroidism (SCH) is defined as an elevated serum thyrotropin level in the presence of normal concentrations. The condition is relatively common and often asymptomatic, although recent meta-analyses have suggested that SCH is associated with increased cardiovascular events and death, especially in young to middle-aged adults, the authors write in their study background. But those epidemiologic associations do not prove that treatment of SCH would be effective, the authors note.

"Thus, only adequately powered randomized controlled intervention trials will be able to demonstrate whether treatment of SCH is worthwhile in terms of improvement in both and symptoms. However, such a trial has not been performed to date and no such trials are ongoing," they comment.

Salman Razvi, M.D., F.R.C.P., of Gateshead Health Foundation Trust and Newcastle University, England, and colleagues used the United Kingdom General Practitioner Research Database to indentify patients with new SCH recorded during 2001 with outcomes analyzed until March 2009. SCH was identified in 3,093 younger patients (40-70 years) and 1,642 older patients (older than 70 years). Levothyroxine was used to treat 52.8 percent of younger patients and 49.9 percent of older patients.

The study results indicate there were 68 incident IHD events among 1,634 younger patients treated with levothyroxine (4.2 percent) vs. 97 events among 1,459 untreated individuals (6.6 percent). In the older group there were 104 events among 819 treated patients (12.7) percent vs. 88 events among 823 untreated patients (10.7 percent).

"In conclusion, treatment with was associated with fewer IHD events and reduced all-cause mortality during an eight-year period of observation in 40 to 70-year-old individuals with SCH but not in those who were older. A prospective randomized controlled trial is required to confirm these findings," the authors conclude.

Explore further: Concern over 'excessive' doses of thyroid drugs for older patients

More information: Arch Intern Med. Published online April 23, 2012. doi:10.1001/archinternmed.2012.1159

Related Stories

Concern over 'excessive' doses of thyroid drugs for older patients

April 29, 2011
Many older adults may be taking "excessive" doses of drugs for thyroid problems which can lead to an increased risk of fractures, finds a study published in the British Medical Journal today.

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.